US 12,257,238 B2
Magnesium biotinate compositions and methods of use
Deanna J. Nelson, Raleigh, NC (US); and James R. Komorowski, Trumbull, CT (US)
Assigned to Nutrition21, LLC, Saddle Brook, NJ (US)
Filed by Nutrition21, LLC, Saddle Brook, NJ (US)
Filed on Feb. 14, 2024, as Appl. No. 18/441,413.
Application 16/855,966 is a division of application No. 15/693,223, filed on Aug. 31, 2017, granted, now 11,938,117.
Application 18/441,413 is a continuation of application No. 16/855,966, filed on Apr. 22, 2020, granted, now 11,931,342.
Claims priority of provisional application 62/382,438, filed on Sep. 1, 2016.
Prior Publication US 2024/0299364 A1, Sep. 12, 2024
Int. Cl. A61K 31/4188 (2006.01); A61G 3/00 (2006.01); A61K 8/19 (2006.01); A61K 8/67 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61Q 3/00 (2006.01); A61Q 5/00 (2006.01); A61Q 7/00 (2006.01)
CPC A61K 31/4188 (2013.01) [A61K 8/19 (2013.01); A61K 8/673 (2013.01); A61K 9/0053 (2013.01); A61K 9/2086 (2013.01); A61K 9/28 (2013.01); A61K 9/2806 (2013.01); A61Q 3/00 (2013.01); A61Q 5/002 (2013.01); A61Q 7/00 (2013.01); A61K 2800/58 (2013.01)] 7 Claims
OG exemplary drawing
 
1. A method of reducing hair loss, improving hair strength, improving hair texture, or a combination thereof in a mammal comprising orally administering a composition comprising an effective amount of isolated crystalline or isolated amorphous magnesium biotinate to the mammal.